Milne Jill C. 4
4 · Astria Therapeutics, Inc. · Filed Feb 12, 2024
Insider Transaction Report
Form 4
Milne Jill C.
DirectorCEO and President
Transactions
- Award
Stock Option (Right to Buy)
2024-02-08+534,600→ 534,600 totalExercise: $15.26Exp: 2034-02-07→ Common Stock (534,600 underlying)
Footnotes (1)
- [F1]This option was granted on February 8, 2024 and is subject to vesting over a four-year period, with 25% of the 534,600 shares underlying the option upon grant vesting on the first anniversary of February 8, 2024 and the remainder vesting over the ensuing three years in equal monthly installments.